Sign in
Not yet taking people in United StatesPhase 2/3

Valproic AcId for Traumatic BRAin INjury Trial

Key facts

Who runs it
Northwestern University
Where
Birmingham, Chicago, Dallas, Los Angeles, Milwaukee, Nashville, Portland, Sacramento, and Tucson, United StatesSee the 9 sites
Trial code
Status
Not yet recruiting
Phase
Phase 2/3
People taking part
432 people, planned
Starts
May 2027
Expected to end
Dec 2031
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Valproic Acid (VPA)
  • Standard of care treatment + normal saline
Record updated
5 November 2026

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Male or female between the ages of 18 and 65 years
  • Body Mass Index between 18 kg/m2 and 35 kg/m2
  • Females must be surgically sterilized, postmenopausal, or have a negative urine pregnancy test
  • Moderate to severe TBI: Glasgow Coma Scale (GCS) 3-12
  • Cerebral trauma confirmed on the initial CT scan with radiographic findings consistent with Brain Injury Guidelines category 3 (BIG 3) criteria

Who cannot take part

  • Persons with a known "do not resuscitate" order prior to randomization
  • Persons with known history of adverse reactions to VPA
  • Persons with known history of hepatitis B or C or clinical history of hepatic dysfunction, pancreatitis, or renal insufficiency
  • Persons with a known history of thrombocytopenia
  • Persons with platelet count less than 100,000 per microliter of blood
  • Persons with 2nd or 3rd degree burns of any size and location
  • Female subjects who are pregnant or lactating
  • Persons who are currently incarcerated or are in police custody
  • Persons with inadequate venous access
  • Treatment cannot start within 120 minutes from the onset of injury
  • Non-survivable injuries in the estimation of the attending trauma surgeon
  • Interfacility transfers
  • The time of injury is unknown
  • Patients in hemorrhagic shock with a systolic blood pressure of <90 mmHg on initial evaluation
  • Persons with a research "opt out" bracelet
  • Persons who are currently enrolled in another clinical trial
  • Greater than 90 minutes between the onset of injury and arrival to the hospital

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • University of Alabama at BirminghamBirmingham, United StatesContact: Joel RodgersNot yet recruiting
  • Northwestern UniversityChicago, United StatesContact: Sharnia Lashley, MSNot yet recruiting
  • University of Texas, SouthwesternDallas, United StatesContact: Katherine BoslerNot yet recruiting
  • University of Southern CaliforniaLos Angeles, United StatesContact: Monica WongNot yet recruiting
  • Medical College of WisconsinMilwaukee, United StatesContact: Madison Rundell, BSNot yet recruiting
  • Vanderbilt University Medical CenterNashville, United StatesContact: Heather WhiteNot yet recruiting
  • Oregon Health Science UniversityPortland, United StatesContact: Samanatha UnderwoodNot yet recruiting
  • University of California - DavisSacramento, United StatesContact: Shari NicholsNot yet recruiting
  • University of ArizonaTucson, United StatesContact: Robin Carlson, PhDNot yet recruiting

About the trial

What the trial wants to find out

The long-term goal of the clinical trial is to develop effective, safe, and easily administered life-saving treatments for patients with moderate to severe traumatic brain injury (TBI).

Read full original descriptionShow less

Patients with moderate to severe TBI will randomly receive either:

1. Standard of care treatment and normal saline 2. Standard of care treatment and one dose of valproic acid (VPA) at a lower dose or a higher dose

The 2 groups in the trial

  • ControlPlacebo, for comparison

    Standard of Care + Normal Saline (0.9% sodium chloride solution)

    Treatment: Standard of care treatment + normal saline

  • ExperimentalTreatment being tested

    Standard of care treatment + one dose of VPA (in 250 ml 0.9% sodium chloride solution) in the following two doses: * Lower dose VPA: 50 mg/kg * Higher dose VPA: 100 mg/kg

    Treatment: Valproic Acid (VPA)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Multi-institutional Phase 2/3 Trial of Valproic Acid in Patients With Moderate to Severe Traumatic Brain Injury
Criteria questions
Built from NCT07166393, who can take part
Publications
Record updated
5 November 2026